Neurochemical Research

, Volume 19, Issue 8, pp 1023–1031 | Cite as

P0 phosphorylation in nerves from normal and diabetic rats: Role of protein kinase C and turnover of phosphate groups

  • Cheryl L. Rowe-Rendleman
  • Joseph Eichberg
Original Articles


The effects of phorbol ester and forskolin on the net phosphorylation and turnover of P0 phosphate groups was studied in normal and exprimentally diabetic rats. In sciatic nerve segments isolated from normal rats and incubated with [32P]-inorganic phosphate, phosphorylation of the major peripheral myelin protein, P0, was increased 2–5 fold in a time and dose-dependent manner by phorbol 12,13 dibutyrate (PDB). This increase was blocked by the protein kinase inhibitors, H-7 and staurosporine. Both the basal and PDB-stimulated phosphorylation of P0 were significantly greater in segments of sciatic nerve from streptozotocin-induced diabetic rats. Prolonged exposure of nerve segments to PDB abolished the stimulated phosphorylation of P0 and immunoblots of nerve proteins revealed a decrease in the content of the protein kinase C α-isoform. The adenylate cyclase activator, forskolin, had no affect on the PDB-stimulated phosphorylation of P0 in normal nerve but decreased phosphorylation in diabetic nerve. To measure turnover of P0 phosphate groups, nerves were incubated with32P and incorporated label was then chased in radioactivity-free medium for up to 4 hours. P0 from normal nerve prelabeled under basal conditions lost 25% of its radioactivity during this time. In contrast, nearly all of the additional phosphate groups prelabeled in the presence of PDB disappeared after 2 hours of chase. P0 phosphate groups from diabetic nerve displayed similar turnover kinetics. When forskolin was added to the chase medium, the turnover of P0 phosphate moieties was accelerated in normal, but not in diabetic nerve. These findings clearly establish a prominent role for protein kinase C in P0 phosphorylation, provide evidence for heterogeneous turnover of P0 phosphate groups and suggest that cyclic AMP-mediated processes may modulate P0 phosphorylation. Further, these results indicate that the metabolism of P0 phosphate moieties is perturbed in nerve from diabetic animals.

Key Words

Peripheral myelin metabolism protein zero protein kinase C diabetic neuropathy protein phosphorylation 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Larocca, J. N., Makman, M. H., Golly, F. and Ledeen, R. W. 1989. The presence of muscarinic receptors linked to phosphoinositide metabolism in myelin. Pages 43–54 in Bazan, N. G., Horrocks L. A. and Toffano, G. (eds.), Phospholipids in the Nervous System: Biochemical and Molecular Pathology, Livania Press, Padova.Google Scholar
  2. 2.
    Day, N. S., Berti-Mattera, L. N. and Eichberg, J. 1991. Muscarinic cholinergic receptor-mediated phosphoinositide metabolism in peripheral nerve. J. Neurochem. 56:1905–1913.Google Scholar
  3. 3.
    Berti-Mattera, L. N., Goraya, T., Mattera, R. and Douglas, J. G. 1992. Identification of G protein subtypes in peripheral nerve and cultured Schwann cells. J. Neurochem. 59:1729–1735.Google Scholar
  4. 4.
    Mathew, J. and Eichberg, J. 1994. GTYγS-mediated stimulation of phosphoinositidase C in solubilized rat peripheral nerve myelin and its alteration in streptozocin-induced diabetes. J. Neurosci. Res. 37:83–91.Google Scholar
  5. 5.
    Greene, D. A., Sima, A. A. F., Stevens, M. J., Feldman, E. L., and Lattimer, S. A. 1992. Complications: neuropathy, pathogenetic complications. Diabetes Care 15:1902–1925.Google Scholar
  6. 6.
    Lowery, J., Berti-Mattera, L. N., Zhu, X., Peterson, R. G., and Eichberg, J. 1989. Relationship of ATP turnover, polyphosphoinositide metabolism, and protein phosphorylation in sciatic nerve and derived peripheral myelin subfractions from normal and streptozotocin diabetic rats. J. Neurochem. 52:921–932.Google Scholar
  7. 7.
    Schrama, L. H., Berti-Mattera, L. N. and Eichberg, J. 1987. Altered protein phosphorylation in sciatic nerve from rats with streptozotocin-induced diabetes. Diabetes 36:1254–1260.Google Scholar
  8. 8.
    Greenfield, S., Brostoff, S., Eylar, E. H., and Morell, P. 1973. Protein composition of myelin of the peripheral nervous system. J. Neurochem. 20:1207–1216.Google Scholar
  9. 9.
    Lemke, G. and Axel, R. 1985. Isolation and sequence of cDNA encoding the major structural protein of peripheral myelin. Cell 40:501–508.Google Scholar
  10. 10.
    Uyemura, K., Suzuki, M., Sakamoto, Y., and Tanaka, S. 1987. Structure of P0 protein: homology to immunoglobulin superfamily. Biomed. Res. 8:353–357.Google Scholar
  11. 11.
    Griffith, L. S., Schmitz, B., and Schachner, M. 1992. L2/HNK-1 carbohydrate and protein-protein interactions mediate the homophilic binding of the neural adhesion molecule P0. J. Neurosci. Res. 33:639–648.Google Scholar
  12. 12.
    Filbin, M. T., Walsh, F. S., Trapp, B. D., Pizzey, J. A. and Tennekoon, G. I. 1990. Role of myelin P0 protein as a homophilic adhesion molecule. Nature 344:871–872.Google Scholar
  13. 13.
    Singh, H. and Spritz, N. 1976. Protein kinases associated with peripheral nerve myelin. I. Phosphorylation of endogenous myelin protein and exogenous substrates. Biochim. Biophys. Acta 448:325–337.Google Scholar
  14. 14.
    Wiggins, R. C. and Morell, P. 1980. Phosphorylation and fucosylation of myelin proteins in vitro by sciatic nerve from developing rats. J. Neurochem 34:627–634.Google Scholar
  15. 15.
    Suzuki, M., Sakamoto, Y., Kitamura, K., Fukunaga, K., Yamamoto, H., Miyamoto, E. and Uyemura, K. 1990. Phosphorylation of P0 glycoprotein in peripheral nerve myelin. J Neurochem. 55:1966–1971.Google Scholar
  16. 16.
    Brunden, K. R. and Poduslo, J. F. 1987. A phorbol ester-sensitive kinase catalyzes the phosphorylation of P0 glycoprotein in myelin. J. Neurochem. 49:1863–1872.Google Scholar
  17. 17.
    Eichberg, J., Berti-Mattera, L. N., Schrama, L., Lin, C-J, Lowery, J., Rowe-Rendleman, C., Zhu, X. and Peterson, R. G. 1989. Phosphoinositide metabolism, protein phosphorylation and the pathogenesis of diabetic neuropathy. Pages 157–166,in Bazan, N. G., Horrocks, L. A., and Toffano, G. (eds.), Phospholipids in the Nervous System: Biochemical and Molecular Pathology, Livania Press, Padova.Google Scholar
  18. 18.
    Agrawal, H. C. and Agrawal, D. 1989. Tumor promoters accentuate phosphorylation of P0: Evidence for the presence of protein kinase C in purified PNS myelin. Neurochem. Res. 14:409–413.Google Scholar
  19. 19.
    Toews, A. D., Fischer, H. R., Goodrum, J. F., Windes, S., and Morell, P. 1987. Metabolism of phosphate and sulfate groups modifying the P0 protein of peripheral nervous system myelin. J. Neurochem. 48:883–887.Google Scholar
  20. 20.
    Smith, P. K., Krohn, R. L., Hermanson, G. T., Mallia, A. K., Gartner, F. H., Provenzano, M. D., Fujimoto, E. K., Goeke, N. M., Olson, B. J. and Klenk, D. C. 1985. Measurement of protein using bicinchoninic acid. Anal. Biochem. 150:76–85.Google Scholar
  21. 21.
    Leli, U., Shea, T. B., Cataldo, A., Hauser, G., Grynspan, F., Beermann, M. L., Liepkalns, V. A., Nixon, R. A. and Parker, P. J. 1993. Differential expression and subcellular localization of protein kinase C α, β, γ, δ and ε isoforms in SH-SY5Y neuroblastoma cells: modifications during differentiation. J. Neurochem. 60:289–298.Google Scholar
  22. 22.
    Steel, R. G. D. and Torrie, J. H. 1960. Principles and Produres in Statistics. McGraw Hill, New York.Google Scholar
  23. 23.
    Ulmer, J. B., Edward, A., McMorris, F. A. and Braun, P. E. 1987. Cyclic AMP decreases the phosphorylation state of myelin basic protein in rat brain cell cultures. J. Biol. Chem. 262:1748–1755.Google Scholar
  24. 24.
    McAtee, P. and Dawson, G. 1989. Rapid dephosphorylation of protein kinase C substrates by protiin kinase A activators results from inhibition of diacylglycerol kinase. J. Biol. Chem. 264:11193–11199.Google Scholar
  25. 25.
    Kikkawa, U., Kishimoto, A. and Nishizuka, Y. 1989. The protein kinase C family: heterogeneity and its implications. Annu. Rev. Biochem. 58:31–44.Google Scholar
  26. 26.
    DesJardins, K. C. and Morell, P. 1983. Phosphate groups modifying myelin basic proteins are metabolically labile; methyl groups are stable. J. Cell. Biol. 97:438–446.Google Scholar
  27. 27.
    Berti-Mattera, L. N., Goraya, T., Douglas, J. G., Day, N. S. and Eichberg, J. 1992. Diminished receptor-mediated polyphosphoinositide breakdown and reduced adenylyl cyclase activity accompany altered G protein levels in diabetic nerve. Diabetes 41 Suppl. 1:22A.Google Scholar
  28. 28.
    Shindo, H., Tawata, M., Onaya, T. 1993. Reduction of cyclic AMP in the sciatic nerve of rats made diabetic with streptozotocin and the mechanism involved. J. Endocrinol. 136:431–438.Google Scholar
  29. 29.
    Kim, J., Rushovich, E. H., Thomas, T. P., Ueda, T., Agranoff, B. A., Greene, D. A. 1991. Diminished specific activity of cytosolic protein kinase C in sciatic nerve of streptozotocin-induced diabetic rats and its correction by dietarymyo-inostiol. Diabetes 40:1545–1554.Google Scholar
  30. 30.
    Ido, Y., Rattarasarn, M., Allson, W., Orfalian, Z. and Arrigoni-Martelli, E. 1993. Effects of acetyl-L-carnitine on functional and metabolic abnormalities in diabetic peripheral nerve. Diabetes 42 Suppl. 1:101A.Google Scholar
  31. 31.
    Hermenegildo, C., Felipo, V., Minana, M-D., Romero, F. J. and Grisolia, S. 1993. Sustained recovery of Na+, K+-ATPase activity in sicatic nerve of diabetic mice by administration of H7 or calphostin C, inhibitors of PKC. Diabetes 42:257–262.Google Scholar
  32. 32.
    Tomlinson, D. R., Ettlinger, C. B. and Lockett, M. J. 1993. Modulation of the sodium/potassium pump of peripheral nerve-pharmacological manipulation of protein kinase C. Mol. Neuropharmacol. 3:133–138.Google Scholar

Copyright information

© Plenum Publishing Corporation 1994

Authors and Affiliations

  • Cheryl L. Rowe-Rendleman
    • 1
  • Joseph Eichberg
    • 1
  1. 1.Department of Biochemical and Biophysical SciencesUniversity of HoustonHouston

Personalised recommendations